Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 3 3 Phase 1 3 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

OTHER 374 INDUSTRY 118 NIH 57 NETWORK 21 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 55 Carcinoma, Non-Small-Cell Lung 33 Stomach Neoplasms 28 Colorectal Neoplasms 26 Small Cell Lung Carcinoma 19 Lung Neoplasms 18 Rectal Neoplasms 16 Pancreatic Neoplasms 14 Neoplasms 14 Neoplasm Metastasis 14 Uterine Cervical Neoplasms 12 Esophageal Neoplasms 12 Ovarian Neoplasms 11 Nasopharyngeal Carcinoma 11 Carcinoma, Hepatocellular 11 Recurrence 10 Leukemia, Myeloid, Acute 10 Melanoma 9 Esophageal Squamous Cell Carcinoma 8 Colonic Neoplasms 8 Triple Negative Breast Neoplasms 7 Lymphoma, Non-Hodgkin 7 Head and Neck Neoplasms 7 Hodgkin Disease 6 Cholangiocarcinoma 6 Adenocarcinoma of Lung 6 Squamous Cell Carcinoma of Head and Neck 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms, Germ Cell and Embryonal 5 Multiple Myeloma 5

Interventions

Temozolomide 1 Radiotherapy 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Glioblastoma × Clear all

NCT02029573 2017-08-18

ART

King Fahad Medical City

Phase 2 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡